Quibim launched QP-Breast in Europe and the United Kingdom on July 2, 2026, as a CE- and UKCA-marked artificial intelligence tool that detects suspicious breast-cancer lesions on MRI scans and generates structured reports for radiologists. The announcement is not another generic “AI in...